Abstract
Summary Twenty patients with oral cancer and ten healthy subjects have been evaluated by the leukocyte adherence inhibition assay using encephalitogenic factor as the antigen. Every cancer patient gave a positive reaction whereas every healthy subject remained negative in this study. The results suggest that the leukocyte adherence inhibition assay performed with encephalitogenic factor can be used as an immune diagnostic tool in oral cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
